Gastrointestinal Adverse Events Observed After Chimeric Antigen Receptor T-Cell Therapy.

CONCLUSION: CART-related GI-AEs occur in 15% of patients treated with CART. These symptoms are typically mild and self-limiting, requiring only symptomatic treatment. Nevertheless, CART may, in rare cases, lead to refractory colitis.
PMID: 31478934 [PubMed - as supplied by publisher]

Source: Clinical Lymphoma and Myeloma - August 29, 2019 Category: Cancer & Oncology Authors: Abu-Sbeih H, Tang T, Ali FS, Luo W, Neelapu SS, Westin JR, Okhuysen PC, Foo WC, Curry JL, Richards DM, Ge PS, Wang Y Tags: Am J Clin Oncol Source Type: research